Cargando…
Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?
Despite being featured as metabolic disorder, diabetic patients are largely affected by hyperglycemia-induced vascular abnormality. Accumulated evidence has confirmed the beneficial effect of endothelial progenitor cells (EPCs) in coronary heart disease. However, antivascular endothelial growth fact...
Autores principales: | Yu, Cai-Guo, Zhang, Ning, Yuan, Sha-Sha, Ma, Yan, Yang, Long-Yan, Feng, Ying-Mei, Zhao, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903148/ https://www.ncbi.nlm.nih.gov/pubmed/27313624 http://dx.doi.org/10.1155/2016/1803989 |
Ejemplares similares
-
Endothelial-to-Mesenchymal Transition in Atherosclerosis: Friend or Foe?
por: Gole, Sarin, et al.
Publicado: (2022) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018) -
Smooth Muscle Progenitor Cells: Friend or Foe in Vascular Disease?
por: van Oostrom, Olivia, et al.
Publicado: (2009) -
Extracellular vesicles and COPD: foe or friend?
por: Wu, Jiankang, et al.
Publicado: (2023) -
Proinsulin C-peptide: Friend or foe in the development of diabetes-associated complications?
por: Nordquist, Lina, et al.
Publicado: (2008)